ORASURE TECHNOLOGIES INC (OSUR) research
ORASURE TECHNOLOGIES INC- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $3.96
- As of
ORASURE TECHNOLOGIES INC (OSUR): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
As of . Source: SEC EDGAR filings for OSUR. Method and limitations.
Share the OSUR intelligence card
See the full OSUR dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for OSUR on one page. Preview it with sample data, then open it live with a free account.
Preview the OSUR dossierActive signals for OSUR
- highCONSENSUS_BUY
3 tracked funds increased OSUR this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +893% to OSUR (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +736% to OSUR (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 132.7%, EPS $0.09 vs $-0.2754 estimate
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 98% of OSUR (2026Q1)
FREE, NO ACCOUNT
Every signal on OSUR, as it fires
You are seeing 5 of 9 signals recorded on OSUR since 2026-05-17.
The five above landed across 4 days. The other 4 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in OSUR (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 68554V108 · 2026Q2 | $9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 68554V108 · 2026Q2 | $3.7M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 68554V108 · 2026Q2 | $840K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 68554V108 · 2026Q2 | $455K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 68554V108 · 2026Q2 | $264K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, OSUR
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
OSUR against its peers
OSUR's operating margin of -62.6% ranks in the 38th percentile of 19 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | OSUR | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 115M USD | 35.3M USD | 92 | 18 |
| Gross margin | 41.9% | 59.8% | 26 | 16 |
| Operating margin | -62.6% | -17.3% | 38 | 19 |
| Net margin | -59.8% | -32.8% | 43 | 19 |
| Return on equity | -20.2% | -17.4% | 45 | 18 |
Peers (20): NNNN, UTMD, EMBC, SMTI, PDEX, NYXH, ZJYL, KRMD, STXS, AVR, MBOT, POCI, KMTS, NEPH, BLFS, MLSS, HBIO, RVP, FEMY, BNGO. Left out: DXR (no annual filing), ZTEK (no annual filing), AZTA (no annual filing), PLSE (no annual filing), OBOCY (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (OSUR: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more OSUR signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to OSURand get the insider, 13F, options, and confluence read in one view.